17 Apr 2026
A recent Today’s Clinical Lab article features Labcorp’s launch of an FDA‑cleared rapid fentanyl urine test that delivers results in just 10 minutes. Designed for use in emergency departments, hospitals, and other Clinical Laboratory Improvement Amendments‑certified settings, the Labcorp Fentanyl Urine Visual Test supports faster clinical decision‑making when fentanyl exposure is suspected.
The article highlights that the test detects norfentanyl, a fentanyl metabolite that can remain detectable for up to 48 hours, extending the window for identifying exposure. Available through Labcorp Point of Care, formerly MEDTOX Diagnostics, the test underscores Labcorp’s commitment to advancing accessible, reliable diagnostics that support patient care in high‑acuity settings.
Read the full article on Today’s Clinical Lab to learn more about the test and its clinical impact.